Breastcancer.org Podcast

Catherine Guthrie is a women’s health journalist with two decades of experience in the magazine and publishing industry. She has written for Cosmopolitan; O, The Oprah Magazine; Slate; Time; and Better Homes and Gardens, among others. In 2009, at age 38, Catherine was diagnosed with breast cancer. Although the cancer was only in one breast, she opted for a double mastectomy and chose not to recons...

Michael Stubblefield, M.D. is medical director of cancer rehabilitation at the Kessler Institute for Rehabilitation in New Jersey and the national medical director for Select Medical’s ReVital Cancer Rehabilitation program. He is known around the world for his expertise in the identification, evaluation, and rehabilitation of pain and functional disorders caused by cancer and cancer treatments, pa...

An adult nurse practitioner, Dori Klemanski, DNP, CNP is clinical director of survivorship at the Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute. In this role she helps identify the unmet needs of cancer survivors, as well as late- and long-term effects of treatment. She also oversees the creation of survivorship care plans to meet the long-te...

Michael Stubblefield, M.D. is medical director of cancer rehabilitation at the Kessler Institute for Rehabilitation in New Jersey and the national medical director for Select Medical’s ReVital Cancer Rehabilitation program. He is known around the world for his expertise in the identification, evaluation, and rehabilitation of pain and functional disorders caused by cancer and cancer treatments, pa...

Michael Kovarik is a retired elementary school teacher who is living with metastatic breast cancer. He is the author of “Healing Within: My Journey with Breast Cancer” and the former host of the Healing Journeys with Michael Kovarik radio show. He was also one of the people profiled in Breast Cancer: A Story Half Told, a campaign to increase public awareness of metastatic breast cancer. Since his...

Dr. Frank DellaCroce, or "Dr. D" as he has come to be known, is a founding partner of the Center for Restorative Breast Surgery and St. Charles Surgical Hospital in New Orleans. Board-certified in plastic surgery, Dr. D has performed thousands of reconstructive procedures, both for women diagnosed with breast cancer and women at high risk of the disease who choose to have prophylactic breast remov...

Dr. Utthara Nayar is a research fellow in medicine at the Dana-Farber Cancer Institute, the Harvard Medical School, and the Broad Institute of MIT and Harvard. A cancer biologist, her broad research focuses on the interface of basic biology, targeted medicines, and drug resistance. At the 2018 American Association for Cancer Research Annual Meeting, she presented research looking at how acquired H...

Dr. C. Kent Osborne is director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, where he is also a professor and the Dudley and Tina Sharp Chair for Cancer Research. Since 1992, he has been a codirector of the San Antonio Breast Cancer Symposium, the world's largest conference focusing entirely on breast cancer. His own research focuses on improving the effectiveness...

Desirée Walker, who calls herself a two-time breast cancer "victor," talks about her poster on the importance of involving patients in breast cancer research projects.

Artist Kathryn Stella, vice president of the Bodice Project, discusses how the sculptural exhibit promotes inner healing among women and men who have been diagnosed with breast cancer.

Dr. Levi Garraway, senior vice president of oncology development and medical affairs at Eli Lilly and Company, discusses some of the research highlights at the 2018 AACR Annual Meeting, particularly those in breast cancer. 

Dr. Jennifer Litton is a board certified medical oncologist and associate professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston. Her research focuses on the genetics of breast cancer and how the genes of a breast cancer change at the molecular level. She has been principal investigator on a number of research projects and is a member of the Genetic/Fa...

Dr. Jennifer Litton is a board certified medical oncologist and associate professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston, where she is chief of the Section of Clinical Research and Drug Development for Breast Cancer. She also is a member of the Breast Immuno-Oncology Task Force of the National Cancer Institute. Listen to the podcast to hear Dr....

Dr. Alexander Miller is a surgical oncologist who specializes in treating breast cancer and people at high risk of the disease. Currently at the START Center for Cancer Care in San Antonio, Texas, he trained at MD Anderson and the Mayo Clinic. Dr. Miller has received awards for excellence in research, education, and patient care. He has been lead or collaborating researcher for several studies on...

Dr. Dawn Hershman is professor of medicine and epidemiology at Columbia University. She also serves as leader of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia and is nationally recognized for her expertise in breast cancer treatment, prevention, and survivorship. A member of the Breastcancer.org Professional Advisory Board, Dr. Hershman also has conducted...

Dr. Sherene Loi is a medical oncologist who specializes in treating breast cancer. In addition to treating patients, particularly patients diagnosed with HER2-positive breast cancer, she also leads the Translation Breast Cancer Genomics and Therapeutics Laboratory at the Peter MacCallum Cancer Centre in Melbourne, Australia, where she is a professor. Much of her clinical research focuses on invest...

Dr. Timothy Pluard is medical director at the Saint Luke’s Cancer Institute and the Koontz Center for Advanced Breast Cancer in Kansas City, Missouri. A medical oncologist, Dr. Pluard specializes in offering comprehensive care, including treatments that use advanced genomics and immunotherapy to women diagnosed with metastatic breast cancer. He also incorporates nutrition planning, spiritual couns...

Beth Fairchild was diagnosed with de novo metastatic breast cancer in 2014 at age 34. The diagnosis was a surprise to her because her mammogram results from the month before were negative, and she had never had a lump in her breast. Beth was familiar with breast cancer though. Her mother was diagnosed with breast cancer at age 44, and her paternal grandmother died from breast cancer at age 33. An...

Beth Fairchild was diagnosed with de novo metastatic breast cancer in 2014 at age 34. The diagnosis was a surprise to her because her mammogram results from the month before were negative and she had never had a lump in her breast. Beth was familiar with breast cancer though. Her mother was diagnosed with breast cancer at age 44 and her paternal grandmother died from breast cancer at age 33. An ar...

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including a study looking at multi-gene panels in BRCA1/BRCA2-positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment. In the wake o...

Dr. Marleen Meyers is a medical oncologist and clinical assistant professor of medicine at NYU Langone. She also serves as director of the Perlmutter Cancer Center Survivorship Program. She received her medical degree from the NYU School of Medicine and has been in practice for more than 20 years. Listen to the podcast to hear Dr. Meyers talk about: what HER2-positive breast cancer is and how its...

Preserving fertility after chemotherapy is an important issue for many, many younger women diagnosed with early-stage breast cancer. Dr. Matteo Lambertini, medical oncologist at the Institute Jules Bordet Brussels, presented research at the 2017 San Antonio Breast Cancer Symposium showing that ovarian suppression with a gonadotropin-releasing hormone analogue such as Lupron, Trelstar, or Zoladex,...

Terry Lynn Arnold, founder of The IBC Network Foundation who was diagnosed with triple-negative inflammatory breast cancer in 2007, talks about how her organization is raising awareness of and funding research on this rare type of breast cancer.

Leisha Emens, associate professor of oncology at Johns Hopkins University School of Medicine and member of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, discusses the state of immunotherapy to treat breast cancer.

Marc Hurlbert, chairperson of the Metastatic Breast Cancer Alliance (MBCA) and chief mission officer of the Breast Cancer Research Foundation, discusses some research presented in San Antonio by MBCA collaborators.